Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Creon (pancrelipase)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0032-3016-13 D-0402-2021
Class II · Moderate risk

Niacin 250mg 110

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0401-2021
Class II · Moderate risk

Therapeutic M 130

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0400-2021
Class II · Moderate risk

ZOMA-Jet 10 Demonstration Kit

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Terminated Packaging defect Ferring Pharmaceuticals Inc D-0318-2021
Class II · Moderate risk

ZOMA-Jet 5 Demonstration Kit

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Terminated Packaging defect Ferring Pharmaceuticals Inc D-0317-2021
Class II · Moderate risk

Omeprazole Delayed-Release Capsules

Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.

Terminated Impurity / degradation Breckenridge Pharmaceutical, Inc NDC 51991-643-10 D-0308-2021
Class II · Moderate risk

Phenylephrine HCl Injection

Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.

Terminated Sterility / contamination Sagent Pharmaceuticals Inc D-0305-2021
Class II · Moderate risk

China-Gel White

CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.

Ongoing cGMP deviation China Gel Inc NDC 76305-301-02 D-0789-2021
Class II · Moderate risk

CHINA_GEL (Camphor 3.00%, Menthol 5.00%)

CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.

Ongoing cGMP deviation China Gel Inc NDC 76305-300-13 D-0788-2021
Class II · Moderate risk

Durisan Antimicrobial Solutions

CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.

Terminated cGMP deviation Sanit Technologies, LLC dba Durisan D-0659-2021
Class II · Moderate risk

Durisan Antimicrobial Solutions

CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.

Terminated cGMP deviation Sanit Technologies, LLC dba Durisan D-0658-2021
Class I · High risk

Durisan Antimicrobial Solutions

Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia contaminans and/or yeast and mold.

Terminated Microbial contamination Sanit Technologies, LLC dba Durisan D-0657-2021
Class I · High risk

Durisan Antimicrobial Solutions

Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia contaminans and/or yeast and mold.

Terminated Microbial contamination Sanit Technologies, LLC dba Durisan D-0656-2021
Class I · High risk

heal the world

Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.

Terminated Labeling / mix-up Pnhc, LLC. D-0365-2021
Class II · Moderate risk

Gabapentin Oral Solution

Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing

Terminated Impurity / degradation Akorn, Inc. D-0301-2021
Class III · Low risk

Romidepsin Injecton

Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0703-4004-01 D-0309-2021
Class I · High risk

Acetaminophen

Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label instead of an OTC drug label.

Terminated Labeling / mix-up A-S Medication Solutions LLC. D-0358-2021
Class II · Moderate risk

Nortriptyline HCL capsules

cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.

Terminated cGMP deviation Direct Rx D-0300-2021
Class III · Low risk

Menopur 75 IU

Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP

Terminated Failed specification Ferring Pharmaceuticals Inc NDC 55566-7501-2 D-0299-2021

Recalls by year